BackNeurometrix Overview

Neurometrix Inventory

Track Neurometrix's inventory ($1.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$1.35M
↓ 13.59% YoYΔ $-211921.00 vs prior year quarter

Peer average

Loading

Neurometrix Inventory History

Loading

Neurometrix vs. peers: Inventory Comparison

Loading

Neurometrix Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Neurometrix (NURO) FAQ

Neurometrix (NURO) currently reports a inventory of $1.3M as of December 2024. That compares with $1.6M in the prior-year period — down 13.6% year over year. Use the charts on this page to explore Neurometrix's inventory history and peer comparisons.

Neurometrix's inventory decreased from $1.6M to $1.3M — a 13.6% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neurometrix reported $1.3M in inventory as of December 2024. That compares with $1.6M in the prior-year period — down 13.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $1.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neurometrix, and consider following NURO for alerts when major investors trade the stock.

Neurometrix is classified in the Healthcare sector. On inventory, it currently shows $1.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NURO with unrelated industries.